Answers are grounded in this paper and cite their sources.
Paroxysmal nocturnal haemoglobinuria (PNH), aplastic anaemia (AA), pancytopenia and myelodysplastic syndromes (MDS) represent important and biologically interconnected disorders of haematopoiesis. Although these conditions differ in their primary mechanisms, considerable clinical and molecular overlap exists, particularly at the level of hematopoietic stem and progenitor cells. PNH results from an acquired somatic defect affecting glycosylphosphatidylinositol (GPI)-anchored proteins, leading to complement-mediated destruction of susceptible blood cells. Aplastic anaemia is predominantly an immune-mediated bone-marrow failure syndrome, whereas MDS represents a heterogeneous group of clonal myeloid neoplasms characterized by ineffective and dysplastic haematopoiesis. Pancytopenia may be a common presenting laboratory manifestation of these disorders but is not itself a diagnosis. Elevated lactate dehydrogenase (LDH), particularly when associated with indirect hyperbilirubinemia, reticulocytosis and reduced haptoglobin, is an important biochemical marker of haemolysis and can be markedly elevated in PNH. Conversely, cytopenias caused by impaired marrow production may produce a different laboratory pattern. Lymphocytosis requires careful interpretation because relative lymphocytosis can occur simply as a consequence of neutropenia or leukopenia, while absolute and persistent lymphocytosis may reflect reactive infection, autoimmune disease or lymphoproliferative disorders. Contemporary diagnosis therefore requires integration of complete blood counts, peripheral blood morphology, haemolysis markers, high-sensitivity flow cytometry using FLAER and GPI-linked markers, bone-marrow morphology, cytogenetics and, where appropriate, molecular studies. This review summarizes the current understanding of these interconnected conditions and emphasizes a systematic approach to patients presenting with unexplained pancytopenia, lymphocyte abnormalities and elevated LDH.
No takes yet. Share an insight, caveat, or question.
Dr. A. K. Dwivedi* (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: